These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

93 related articles for article (PubMed ID: 5400636)

  • 41. [E-aminocaproic acid, an inhibitor of fibrinolysis].
    Chaplygina ZA; Beznosikova VK
    Probl Gematol Pereliv Krovi; 1965 Aug; 10(8):17-20. PubMed ID: 5868997
    [No Abstract]   [Full Text] [Related]  

  • 42. [Research on the influence of sodic epsilon-aminocaproate on the cardiovascular system. II. Difference of response of the cerebral circulation of the rabbit to intra-carotid injection of epsilon-aminocaproate of sodium and its N-benzoyl derivative].
    Mucci P; Saviano MS; Sternieri E
    Boll Soc Ital Biol Sper; 1968 Jun; 44(11):945-8. PubMed ID: 5687293
    [No Abstract]   [Full Text] [Related]  

  • 43. [Properties of a new drug: epsilon aminocaproic acid].
    Prezioso M
    Friuli Med; 1967; 22(2):445-51. PubMed ID: 5607706
    [No Abstract]   [Full Text] [Related]  

  • 44. [Influence of epsilon-aminocaproic acid on the growth of tumor cells in immunized mice].
    Bonmassar E; Celi ML; Melan F; Testorelli C
    Arch Ital Patol Clin Tumori; 1968; 11(1):187-94. PubMed ID: 5745501
    [No Abstract]   [Full Text] [Related]  

  • 45. [Anti-bradykininase activity in vitro of epsilon-aminocaproic acid and of some of its derivatives on rat uterus homogenates].
    Baraldi M; Poggioli R; Vertecky G
    Boll Soc Ital Biol Sper; 1969 Apr; 45(7):438-40. PubMed ID: 5390005
    [No Abstract]   [Full Text] [Related]  

  • 46. Effects of endotoxin on pulmonary capillary permeability, ultrastructure, and surfactant.
    Harrison LH; Beller JJ; Hinshaw LB; Coalson JJ; Greenfield LJ
    Surg Gynecol Obstet; 1969 Oct; 129(4):723-33. PubMed ID: 5821229
    [No Abstract]   [Full Text] [Related]  

  • 47. [The effect of epsilon-aminocaproic acid administered to parturient women on the blood coagulation system of the newborn].
    Budyka LA
    Vopr Okhr Materin Det; 1968 Jan; 13(1):31-4. PubMed ID: 5719518
    [No Abstract]   [Full Text] [Related]  

  • 48. [Animal experimental studies of the effect of synthetic antifibrinolytics].
    Markwardt F; Klöcking HP
    Acta Biol Med Ger; 1966; 17(6):746-54. PubMed ID: 5990894
    [No Abstract]   [Full Text] [Related]  

  • 49. [The hemostatic effect of 5-aminocaproic acid].
    Shvarsalon NS; Zaĭtseva RI
    Farmakol Toksikol; 1965; 28(6):704-7. PubMed ID: 5876372
    [No Abstract]   [Full Text] [Related]  

  • 50. [Studies on the effect of oral contraceptives and epsilon-aminocaproic acid on pregnant rats and their fetuses with particular attention to the coagulation tests].
    Niznikowska-Marks MJ; Oknińska A; Gawlik Z; Ostojska J; Grygalewicz J; Galczak W
    Pediatr Pol; 1980 Jul; 55(7):849-57. PubMed ID: 6158732
    [No Abstract]   [Full Text] [Related]  

  • 51. [Anti-protease activity of some derivatives of epsilon-aminocaproic acid].
    Bertelli A; Donati L; Rossano MA
    Boll Soc Ital Biol Sper; 1964 Dec; 40(24):Suppl:1924-6. PubMed ID: 5875467
    [No Abstract]   [Full Text] [Related]  

  • 52. [Experimental basis permitting an estimation of the effectiveness of substances with capillarovenous action].
    van Cauwenberge H; Lecomte J; Franchimont P
    Angeiologie; 1968; 20(4):13-23. PubMed ID: 5710180
    [No Abstract]   [Full Text] [Related]  

  • 53. [Effects of epsilon-aminocaproic acid on potassium 42 content of erythrocytes].
    Grabowski R; Bielawiec M; Wojtowicz Z
    Pol Tyg Lek; 1970 Dec; 25(52):2025-7. PubMed ID: 5495541
    [No Abstract]   [Full Text] [Related]  

  • 54. [Comparative effectiveness of epsilon-aminocaproic acid and contrical in preventing complement activation on immune complexes].
    Tsibul'kin AP; Raĭzman SM
    Farmakol Toksikol; 1981; 44(3):316-9. PubMed ID: 6169545
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Activity of epsilon-aminocaproic acid in some microbiological assay systems for lysine.
    Bolinder AE
    Acta Pharm Suec; 1966 Jun; 3(3):181-6. PubMed ID: 4961178
    [No Abstract]   [Full Text] [Related]  

  • 56. [Administration of epsilon-aminocaproic acid].
    Hrodek O
    Cesk Pediatr; 1968 May; 23(5):465-7. PubMed ID: 5660458
    [No Abstract]   [Full Text] [Related]  

  • 57. [Increased pulmonary vascular permeability after injection of oleic acid].
    Hara N; Furukawa T; Motohiro H; Yoshida T; Inokuchi K
    Nihon Kyobu Shikkan Gakkai Zasshi; 1982 Sep; 20(9):967-73. PubMed ID: 7154446
    [No Abstract]   [Full Text] [Related]  

  • 58. The effects of infusing thrombin and its acetylated derivative. I. Studies of coagulation and fibrinolysis.
    Pechet L; Engel AM; Goldstein C; Glaser B
    Thromb Diath Haemorrh; 1968 Nov; 20(1):190-201. PubMed ID: 5751381
    [No Abstract]   [Full Text] [Related]  

  • 59. [Epsilon-aminocaproic acid in the fibrinolutic process after open heart surgery].
    García Cornejo M; Christlieb I; Barbabosa E; Corona E
    Arch Inst Cardiol Mex; 1968; 38(4):580-6. PubMed ID: 5685455
    [No Abstract]   [Full Text] [Related]  

  • 60. Incidence of thrombosis associated with epsilon-aminocaproic acid administration and with combined epsilon-aminocaproic acid and subcutaneous heparin therapy. A study in experimental animals and in clinical material.
    Becker J; Borgström S
    Acta Chir Scand; 1968; 134(5):343-9. PubMed ID: 5731268
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 5.